TSMC Earnings Show AI Growth Amid CapEx Pressure

TSMC earnings showed robust Q2 growth and raised 2026 revenue guidance while boosting capital spending that may pressure near-term margins.

September 25, 2026·2 min read
View all news articles
Flat vector of a chip wafer expanding to symbolize TSMC earnings tradeoff between AI growth and higher capex.

KEY TAKEAWAYS

  • TSMC reported strong Q2 revenue growth and raised full-year 2026 dollar-revenue guidance.
  • Management set Q3 revenue guidance at $44.6B-$45.8B with gross-margin guidance of 65%-67%.
  • 2026 capex was increased to $60B-$64B, heightening near-term margin risk from the 2nm ramp.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) reported on July 16, 2026, that rising AI demand is boosting its business as management raised 2026 revenue guidance. However, stepped-up capital spending and the ramp-up of its 2-nanometer process are expected to pressure near-term margins.

Earnings, Guidance, and AI Demand Exposure

TSMC’s second-quarter 2026 revenue rose 33.7% year over year, with a gross margin of 67.7% and an operating margin of 60.3%. Management raised full-year 2026 dollar-revenue growth guidance to slightly above 40% and set third-quarter revenue guidance between $44.6 billion and $45.8 billion, assuming an exchange rate of NT$32 per U.S. dollar. The company also projected a third-quarter gross margin of 65% to 67%.

The chipmaker is widely viewed as a broad beneficiary of AI infrastructure spending because it manufactures chips designed by multiple customers, including Nvidia and AMD. This characterization is analytical and not a company forecast.

Capital Spending, Margin Pressure, and Packaging Expansion

TSMC increased its 2026 capital-expenditure plan to $60 billion to $64 billion, intensifying the tradeoff between expanding capacity and preserving near-term margins. In the June quarter, capital spending reached $15.6 billion, about 42% higher than the prior quarter’s $11.0 billion. Operating cash flow for the period was approximately $24.5 billion, while dividends totaled roughly $4.9 billion.

The company expects the 2-nanometer production ramp to reduce near-term margins by about 3 to 4 percentage points. This, combined with the third-quarter gross-margin guidance, suggests potential sequential margin pressure from the second quarter.

Advanced packaging capacity remains tight, prompting TSMC to expand operations. The company broke ground on a packaging-validation park in Kaohsiung on Sept. 21, 2026, with operations targeted for the fourth quarter of 2029. This expansion aims to meet demand from Nvidia and other chip designers.

The combination of strong revenue growth driven by AI demand and a significantly larger capital budget highlights the central challenge for TSMC: balancing robust top-line momentum with heavy near-term investment that may compress margins while building multi-year capacity.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Microsoft Copilot Expanded With Home, Code and Autopilot

Microsoft Copilot Expanded With Home, Code and Autopilot

Microsoft Copilot expands with Home, Code and Autopilot and adds Office integration; Frontier and private-preview rollouts may shift trader positioning.

Micron Stock Price Targets Lift Bull Case Before Earnings

Micron Stock Price Targets Lift Bull Case Before Earnings

Micron stock price targets rose as AI memory demand bolstered Micron earnings guidance, prompting traders to position ahead of the Sept. 30 fiscal-Q4 report.

SCHD Dividend ETF Draws Income Attention

SCHD Dividend ETF Draws Income Attention

SCHD dividend ETF drew attention after an ex-dividend payout, prompting traders to weigh its higher yield and one-year outperformance versus VYM.

Novo Nordisk Nanexa Deal Advances Injectables

Novo Nordisk Nanexa Deal Advances Injectables

Novo Nordisk Nanexa deal gives Novo access to PharmaShell for long-acting injectable programs and shifts trader focus to cardiometabolic R&D.

Polymarket Lawsuit Escalates in New York

Polymarket Lawsuit Escalates in New York

Polymarket lawsuit alleges unlicensed gambling and seeks injunctions and treble fines, raising regulatory risk and trader scrutiny for prediction markets.

Meta Muse AI Expands With New Features

Meta Muse AI Expands With New Features

Meta Muse AI will add real time voice, avatar, connectors and email and reach Meta's glasses, widening touchpoints that could enable monetization.